Rx Import Bills Do Not Have Adequate Funding For FDA, Agency Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate bills "do not go far enough" in allowing FDA to assure safety and efficacy of imported drugs, FDA's Hubbard tells Judiciary Committee hearing. Senate Health Committee will mark up Sen. Gregg's import bill July 21.
You may also be interested in...
Rx Import Status In Senate Judiciary Committee Could Shift Under Specter
Outgoing Judiciary Chairman Hatch (R-Utah) used hearings on importation to point out legal problems. His likely successor, Sen. Specter (R-Penn.), is a cosponsor of Rx import legislation.
Rx Import Status In Senate Judiciary Committee Could Shift Under Specter
Outgoing Judiciary Chairman Hatch (R-Utah) used hearings on importation to point out legal problems. His likely successor, Sen. Specter (R-Penn.), is a cosponsor of Rx import legislation.
Rx Import Bill Mark-Up Postponed
The Senate Health Committee's mark-up of Sen. Judd Gregg's (R-N.H.) drug importation bill scheduled for July 21 has been postponed due to the expected signing of "BioShield" legislation by President Bush.